AstraZeneca reports positive results for phase 2 COAST trial of oleclumab and monalizumab

AstraZeneca has reported positive results from the COAST phase 2 trial of its oleclumab or monalizumab in combination with Imfinzi (durvalumab) in patients with non-small ... Read More